Skip to main content Help with accessibility Skip to main navigation

Semaglutide

Indication

Treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy when metformin is considered inappropriate due to intolerance or contraindications; or in addition to other medicinal products for the treatment of diabetes.
NICE NG28 - Type 2 diabetes in adults: management
Green

Brand:

Ozempic ®

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Endocrine system

Background

The GLP‑1 agonist Semaglutide is indicated in adults with type 2 diabetes mellitus to improve glycaemic control.
NICE Guideline 28 only recommends the prescribing of GLP‑1 agonists in the add-on therapy setting; therefore Semaglutide was reviewed only in the add-on therapy setting.
Semaglutide recommended as an option in line with NICE Guideline 28

Recommendation

LSCMMG Recommendation:

Green

Reason for decision:

Suitable for initiation in primary care

Decisions of Lancashire local decision making groups

Green
Green
Green
Green
Green
Green
Green
Green
What do the colours mean?

Last Updated: 01 - Sep - 2018